Multiple sclerosis (MS) is considered an autoimmune disorder that affects the myelin sheaths of in the central nervous system (CNS). The body’s immune system attacks its own tissues. But a substance called Gc protein-derived macrophage-activating factor (GcMAF) is able to reintegrate the body’s immune cells, especially its T cells and B cells. Both types are held responsible for “abnormal interactions between T cells and B cells are implicated in the immunopathogenesis of MS.”

With the limited effective treatment options available for MS, one study treated a 45-year-old male MS patient with colostrum MAF.

“This case study demonstrated that treatments of GcMAF in a patient with MS have potent therapeutic actions with early beneficial responses, especially improvement of motor dysfunction,” said the researchers.

“After treatment, the patient exhibited increased energy and, after four years of being confined to a wheelchair, was able to walk. Importantly, all medications for pain and urinary bladder control and antibiotics were discontinued, and the patient could navigate stairs.”

The MS case study showed that treatment with colostrum MAF “markedly improved the motor ability. The study suggests that using immunomodulation via MAF could be beneficial in the treatment of MS.”

Earlier Research

This is the second study I have come across that documents the use of BC for MS. In a study published in 1984, specially produced colostrum was orally administered every morning to 15 patients with MS at a daily dosage of 100 milliliters for 30 days.

As a result, among seven high-symptom patients, five recipients improved and two remained unchanged. Among eight low-symptom patients, five patients improved and three remained unchanged. Among five patients receiving the placebo, two remained unchanged and three worsened. No side effects were observed in colostrum recipients.

“These findings suggest the efficacy of orally administered anti-measles colostrum in improving the condition of MS patients.”

Bovine colostrum is a safe food, easy to obtain, and a non-inducer of inflammatory cytokines, say researchers, noting its promise for MS patients.